Today: 21 May 2026
AppLovin (NASDAQ: APP) stock dips today as year-end tech pullback pressures growth names
31 December 2025
2 mins read

AppLovin (NASDAQ: APP) stock dips today as year-end tech pullback pressures growth names

NEW YORK, December 31, 2025, 14:13 ET — Regular session

  • AppLovin shares fell 1.3% to $685 in afternoon trading, after swinging between $682.73 and $698.23.
  • The stock is under pressure in thin, year-end trading as investors rebalance away from high-priced growth names.
  • Treasury yields edged higher after jobless claims fell, keeping the market focused on January economic data and the Fed.

AppLovin Corp shares fell 1.3% to $685.00 in afternoon trading on Wednesday. The stock ranged between $682.73 and $698.23.

The move tracked a modest dip in major U.S. indexes in the final trading session of 2025, with technology shares among the biggest drags as holiday-thinned liquidity amplified small swings.

Treasury yields ticked higher after new data showed jobless claims fell to 199,000 in the week ended Dec. 27, undershooting economists’ expectations for a rise. Higher yields raise the discount rate investors use to value future profits, a headwind for growth stocks priced on earnings years out.

The Invesco QQQ Trust, a proxy for the Nasdaq 100, was down about 0.2% in afternoon trading, while the S&P 500-tracking SPDR fund slipped a similar amount. AppLovin was underperforming both benchmarks.

Several ad-tech and app-economy names traded unevenly. Unity Software fell about 1% and Magnite was down roughly 0.7%, while The Trade Desk edged higher.

Mark Hackett, chief market strategist at Nationwide, described the recent weakness as a repositioning rather than a panic. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” Hackett said. Reuters

AppLovin runs a marketing platform that helps developers and advertisers buy, place and measure mobile ads, and sells analytics tools through its Adjust unit. Its products include AppDiscovery and the MAX in-app bidding platform, alongside the Axon software it uses to optimize ad targeting.

In its Nov. 5 quarterly report, AppLovin said revenue rose 68% from a year earlier to $1.405 billion and it generated $1.05 billion in free cash flow. The company also increased its share repurchase authorization — a buyback program — to $3.3 billion remaining as of end-October, and guided fourth-quarter revenue of $1.57 billion to $1.60 billion. It forecast adjusted EBITDA, a profit measure that strips out some costs such as interest and taxes, of $1.29 billion to $1.32 billion.

Regulatory scrutiny has also hovered over the stock. Reuters reported in October that the U.S. SEC was probing AppLovin over data-collection practices tied to its ad business.

For the broader market, investors are watching the Federal Reserve’s path after minutes from its December meeting showed deep divisions over the latest rate cut. The minutes flagged a restart of key releases after the government shutdown, including December jobs data on Jan. 9 and consumer price data on Jan. 13, ahead of the Fed’s Jan. 27-28 meeting.

U.S. stock markets are closed on Thursday for New Year’s Day and reopen on Jan. 2. That calendar, along with year-end positioning, has kept trading volumes light and price action choppy.

For AppLovin, traders will be watching whether the stock holds above this week’s lows and whether the move higher in yields extends into early January. A sustained rise in rates can keep pressure on high-multiple growth stocks because more of their valuation depends on future earnings.

Stock Market Today

  • Stock Market Futures Fall on May 20, 2026, as Investors React to Nvidia Earnings
    May 20, 2026, 7:32 PM EDT. U.S. stock futures dropped Wednesday evening, reflecting investor caution after Nvidia ($NVDA) reported earnings. The AI chipmaker's results sparked debate over whether they met lofty expectations, influencing market sentiment ahead of Thursday's open. Futures contracts, which allow investors to buy or sell assets at a predetermined price for future delivery, indicated a tentative market tone. Traders are assessing Nvidia's outlook amid broader concerns about the tech sector's growth momentum and valuation pressures. This cautious stance highlights the sensitive market environment as investors balance strong earnings reports against economic headwinds and sector-specific risks.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop